Replies to post #199722 on Elite Pharmaceuticals Inc (ELTP)

[YJ4LIFE]

Wow another misinformation/bs. Thanks timmyvc duy. Sign of desperation from VC!

[BuddyGuise]

Volume is already half of our 10 day average, in a little more than an hour. More lies and diceit, happy to debunk!

[kennyt 335]

Explain, why the heck are you here then if your feelings of the company are what you say? Another agenda perhaps? Lmao at you and a few others but all in fun, lmao at myself for that one!!!! Only post for today... bye

[Couch]

LMMFAO literally- best inform the FDA that they've given out 5 ADT labels for drugs that don't detour swallowing a hand full of pills.

THANKS for the laugh :)

[lasers]

Pathetic. You need more DD to determine the differences of SequestOx vs KMPH APAP drug!!!!

[mrwrn2010]

Hydrocodone/Acetaminophen prodrug technology does NOT equal Oxycodone/Naltrexone sequestered antagonist technology. More DD is clearly in order. LOL.

[BuddyGuise]

Get your facts first, then you can distort them as you please. - Mark Twain - ELTP on the cusp of being the first ADF IR Oxy on the market! More importantly, approval will provide the proof of concept for ELTP ADF modular technology good for any opioid combination...$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

[rollin2nyte]

Are you serious? That's gotta be the most blatant piece of misinformation I've ever heard on this board.

[Opportunity Strikes]

NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM (ELI-200), Elite’s lead opioid abuse-deterrent candidate for the management of moderate to severe pain where the use of an opioid analgesic is appropriate, has been accepted and granted priority review by the United States Food and Drug Administration (“FDA”). The FDA has set a target action date under the Prescription Drug User Fee Act (“PDUFA”) of July 14, 2016.

SequestOxTM is an immediate-release Oxycodone Hydrochloride containing sequestered Naltrexone which incorporates 5 mg, 10 mg, 15 mg, 20 mg and 30 mg doses of oxycodone into capsules.

“The FDA’s decision to grant Priority Review to the SequestOxTM submission is an important milestone for Elite and an important step toward providing a new treatment option for physicians and patients that may deter some of the common methods of opioid abuse,” said Nasrat Hakim, President and Chief Executive Officer of Elite. “I am pleased with the targeted PDUFA date and we look forward to the FDA’s review of our submission.”

I think that we will just leave it up to the FDA to make the determination and bypass your speculations.

[namtae]

Very informative.. Is this another reason ELTP continues to dilute shareholders and new shares are entering the market by the millions suffocating the share price?

There are no buyer coming in as volume is anemic. It is obvious that SequestOx will not get Abuse deterrent labeling. FDA is clear when they denied KMPH abuse deterrent labeling. Any technology that does not address core issue of addiction through ingestion will not be allowed ADL. Insurance companies will not reimburse without ADL. ELTP will crash without Abuse deterrent labeling same as KMPH. ELTP is just another company that claim Abuse deterrent technology without solving the main problem, Opioid Ingestion.

I was hearing similar feelings from experts in the field.

Explains why institutions wont touch ELTP (0.2% ownership)and shares struggle on a daily basis within a couple cent spread

Something is very wrong here. Smart people recognize this.

[NASDAQ2020]

KMPH doesn't not have an abuse deterrent labeling because it does not compare to Elite's first in class novel, modular 2 bead ADFormulation.
Elites tech will soon be the standard of care in pain care/

[NASDAQ2020]

HAL studies had stellar results: Positive
ADF labeling guaranteed
Elite will CONTROL the ENTIRE Immediate Release ADF Oxycodone market on or before July 14, 2016.
ALL other IR ADFs will have to be as good or better than Elites new Standard of Care.
Elite has raised the bar for any future competition .
For now Elite OWNS the IR ADF oxy market.
No other non ADF IR oxy can be filed going forward.